CreditReports.dk
HomeScreen companies

Combotope Therapeutics ApS Financials, key figures and credit report

CVR number: 44308266 Established 2023 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Ole Maaløes Vej 3, 2200 København N olablixt@combotope.com
Gross profit - 633.4 kDKK FY 2025 +69.3% vs 2024
EBIT -1 197.8 kDKK FY 2025 +57.3% vs 2024
Net debt -98.8 kDKK FY 2025 +79.8% vs 2024
Quick ratio 54.8 FY 2025 +9.4 vs 2024

Income statement (kDKK)

2024
2025
Fiscal period length1212
Net sales
Gross profit-2 059.79- 633.36
Employee benefit expenses- 733.67- 548.71
Total depreciation-9.17-15.72
EBIT-2 802.63-1 197.79
Other financial income2.690.13
Other financial expenses-1.55-0.13
Pre-tax profit-2 801.49-1 197.78
Income taxes616.18263.39
Net earnings-2 185.31- 934.39

Assets (kDKK)

2024
2025
Intangible assets total
Machinery and equipment69.4353.71
Tangible assets total69.4353.71
Investments total130.4416.36
Long term receivables total
Inventories total
Prepayments and accrued income26.14
Current other receivables50.5040.46
Current deferred tax assets616.18879.57
Short term receivables total692.82920.03
Cash and bank deposits487.9798.77
Cash and cash equivalents487.9798.77
Balance sheet total (assets)1 380.671 088.87

Equity and liabilities (kDKK)

2024
2025
Share capital55.3063.30
Share premium account3 484.70642.00
Retained earnings1 299.39
Profit of the financial year-2 185.31- 934.39
Shareholders equity total1 354.691 070.29
Non-current liabilities total
Current trade creditors10.00
Other non-interest bearing current liabilities25.988.57
Current liabilities total25.9818.58
Balance sheet total (liabilities)1 380.671 088.87
Page generated